Prudent Man Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$479K Buy
5,523
+1,919
+53% +$184K 0.14% 112
2025
Q4
$346K Buy
3,604
+95
+3% +$9.23K 0.13% 115
2025
Q3
$334K Sell
3,509
-3,026
-46% -$278K 0.12% 115
2025
Q2
$570K Sell
6,535
-4
-0.1% -$339 0.18% 116
2025
Q1
$588K Buy
6,539
+182
+3% +$16.3K 0.21% 109
2024
Q4
$508K Sell
6,357
-1,035
-14% -$89.6K 0.18% 115
2024
Q3
$666K Sell
7,392
-24
-0.3% -$2.02K 0.22% 109
2024
Q2
$584K Buy
7,416
+287
+4% +$23.5K 0.21% 109
2024
Q1
$621K Hold
7,129
0.23% 104
2023
Q4
$587K Sell
7,129
-370
-5% -$28.2K 0.22% 105
2023
Q3
$588K Sell
7,499
-9
-0.1% -$753 0.23% 101
2023
Q2
$661K Sell
7,508
-157
-2% -$13.5K 0.25% 88
2023
Q1
$618K Sell
7,665
-31
-0.4% -$2.53K 0.24% 97
2022
Q4
$598K Buy
7,696
+31
+0.4% +$2.51K 0.24% 103
2022
Q3
$619K Buy
7,665
+314
+4% +$28.2K 0.29% 72
2022
Q2
$660K Sell
7,351
-13
-0.2% -$1.32K 0.31% 64
2022
Q1
$817K Sell
7,364
-119
-2% -$12.6K 0.33% 58
2021
Q4
$774K Sell
7,483
-1,021
-12% -$118K 0.29% 66
2021
Q3
$1.07M Buy
8,504
+23
+0.3% +$2.98K 0.4% 53
2021
Q2
$1.05M Buy
8,481
+442
+5% +$55.5K 0.41% 52
2021
Q1
$950K Buy
8,039
+275
+4% +$32.2K 0.4% 53
2020
Q4
$909K Sell
7,764
-258
-3% -$28.4K 0.38% 51
2020
Q3
$834K Buy
8,022
+5,344
+200% +$537K 0.44% 50
2020
Q2
$246K Buy
+2,678
New +$257K 0.22% 120

Other funds holding MDT

Prudent Man Advisors's MDT Position: Q1 2026 in Review

Prudent Man Advisors increased its Medtronic (MDT) stake by 53% in Q1 2026, buying an estimated $184K and bringing the position to 5,523 shares worth $479K. The position accounts for 0.14% of the portfolio, ranked #112.

Prudent Man Advisors first reported a position in MDT in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.07M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Prudent Man Advisors held 5,523 shares of Medtronic worth $479K as of Q1 2026.
  • Prudent Man Advisors bought 1,919 Medtronic shares in Q1 2026, an estimated $184K.
  • Medtronic made up 0.14% of Prudent Man Advisors's portfolio in Q1 2026, its #112 holding.
  • Prudent Man Advisors first reported a position in Medtronic in Q2 2020 and has held it in 24 quarters since.
  • Prudent Man Advisors's Medtronic position peaked at $1.07M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Prudent Man Advisors's 13F filing for Q1 2026, filed 8 May 2026.